Identification of Undiagnosed Gaucher Disease
Primary Purpose
Gaucher Disease
Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Enzyme analysis
Sponsored by
About this trial
This is an interventional diagnostic trial for Gaucher Disease focused on measuring Gaucher disease, lysosomal storage disorder, metabolic disease, medical records review
Eligibility Criteria
Inclusion Criteria:
- Must have records available in the Partners HealthCare Patient Data Registry
Exclusion Criteria:
- Must not have a diagnosis of Gaucher disease
Sites / Locations
- Brigham and Women's Hosptial
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Enzyme analysis
Arm Description
Patients invited for evaluation will undergo glucocerebrosidase enzyme analysis
Outcomes
Primary Outcome Measures
number of patients with previously undiagnosed GD identified
Secondary Outcome Measures
Full Information
NCT ID
NCT01716741
First Posted
October 26, 2012
Last Updated
October 26, 2012
Sponsor
Brigham and Women's Hospital
Collaborators
Genzyme, a Sanofi Company
1. Study Identification
Unique Protocol Identification Number
NCT01716741
Brief Title
Identification of Undiagnosed Gaucher Disease
Official Title
Identification of Undiagnosed Gaucher Disease
Study Type
Interventional
2. Study Status
Record Verification Date
August 2012
Overall Recruitment Status
Unknown status
Study Start Date
August 2012 (undefined)
Primary Completion Date
August 2014 (Anticipated)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Brigham and Women's Hospital
Collaborators
Genzyme, a Sanofi Company
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Partners HealthCare maintains a Patient Data Registry (PDR) with information from all patient encounters at Partners HealthCare facilities. We intend to utilize the PDR to identify groups of patient who are of high clinical suspicion for undiagnosed Gaucher disease. A group of potential participants will be identified through the PDR. Detailed records will be requested to further narrow to ideal participants based upon previously existing diagnoses and symptoms. Participants will be invited to partake in the study via a letter from their Partners care provider with supporting study details. Study participants will be evaluated in a one-time visit. A complete family and medical history will be collected. A physical exam will be performed, and up to 20cc of blood will be drawn. All participants will be notified of their disease status via letter and phone call from the study staff. If the study participant is diagnosed with GD through this evaluation, proper follow-up recommendations and referrals will be provided. Our intent is to determine if existing patient data can successfully be utilized to aid in the identification of patients with rare genetic disease.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gaucher Disease
Keywords
Gaucher disease, lysosomal storage disorder, metabolic disease, medical records review
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Enzyme analysis
Arm Type
Other
Arm Description
Patients invited for evaluation will undergo glucocerebrosidase enzyme analysis
Intervention Type
Other
Intervention Name(s)
Enzyme analysis
Primary Outcome Measure Information:
Title
number of patients with previously undiagnosed GD identified
Time Frame
up to 2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Must have records available in the Partners HealthCare Patient Data Registry
Exclusion Criteria:
Must not have a diagnosis of Gaucher disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael F Murray, MD
Organizational Affiliation
Brigham and Women's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Brigham and Women's Hosptial
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Identification of Undiagnosed Gaucher Disease
We'll reach out to this number within 24 hrs